Sydney Adventist Hospital 02 9487 9111


Sydney Adventist Hospital
« View pages

Our Services

Authorised Prescriber

An accredited medical officer engaged in clinical practice within Adventist HealthCare Limited will only prescribe unapproved therapeutic goods under section 19(5) of the Therapeutic Goods Act to patients under their care, after receiving endorsement as an Authorised Prescriber, from the Ethics Committee. The Committee will provide a letter of endorsement as part of the practitioner’s application to the Therapeutic Goods Administration (TGA). 

An Adventist HealthCare Limited pharmacy will only dispense unapproved therapeutic goods to an accredited medical officer engaged in clinical practice within Adventist HealthCare Limited who has received endorsement as an Authorised Prescriber from the Ethics Committee and the TGA.


Procedure

An accredited medical officer will comply with the Human Research Ethics Committee Standard Operating Procedures when requesting endorsement as an Authorised Prescriber.

  • For endorsement to supply a medical device a written request must be submitted to the HREC which includes the following: 
  • Indication – Condition for which the product will be prescribed 
  • Clinical Justification 
  • Product details: Name of medical device / supplier 
  • Dosage / route or method of administration and duration of treatment 
  • Efficacy and safety data 
  • Prescriber’s name, postal address, phone number / qualifications 
  • Site/s at which the product is to be used 
  • Anticipated patient numbers 
  • Anticipated commencement date 
  • Proposed method of tracking devices 


For endorsement to supply medicine a written request must be submitted to the HREC which includes the following:

  • Indication – Condition for which the product will be prescribed 
  • Clinical Justification 
  • Product details: Class of drug / trade name / generic name / supplier 
  • Dosage / route or method of administration and duration of treatment 
  • Efficacy and safety data 
  • Prescriber’s name, postal address, phone number / qualifications 
  • Site/s at which the product is to be used 
  • Anticipated patient numbers 
  • Anticipated commencement date 


A Participant Information Statement must be submitted to the HREC which includes the following information:

  • That the product is not approved for marketing in Australia 
  • Identify any benefits of treatment 
  • Identify any known risks and side effects of treatment 
  • Alternative treatment using approved products, if available 


Participants are required to give written Consent to receive unapproved therapeutic goods. The form of Consent - Authorised Prescriber Use must comply with the standard Adventist HealthCare Limited template.

If the application is to supply unapproved products derived from biological tissue including human blood or plasma, the Consent must advise that the TGA offers no guarantee as to its quality, safety or efficacy, particularly in regards to prion or viral inactivation. The TGA template Consent to Treatment for use of Products Derived from Biological Tissue Including Human Blood or Plasma must be used.

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services